Literature DB >> 17149716

Salvage hepatic resection after incomplete interstitial therapy for primary and secondary liver tumours.

G Torzilli1, D Del Fabbro, A Palmisano, M Marconi, M Makuuchi, M Montorsi.   

Abstract

BACKGROUND: When the response to percutaneous ablation therapy (PAT) of liver tumours is incomplete, surgery may be undertaken as a salvage therapy. To validate the safety and effectiveness of salvage hepatectomy, patients who had undergone PAT or no treatment before hepatectomy were compared.
METHODS: Of 137 patients who had hepatectomy for primary and secondary tumours, 21 had undergone PAT and 116 had surgery as primary treatment. Tumour features and the incidence of liver cirrhosis were similar in the two groups.
RESULTS: Peroperative mortality and major morbidity rates were zero and 5 per cent (one of 21) respectively among patients who had PAT before surgery, and 0.9 per cent (one of 116) and zero in those who did not. Duration of operation (mean 495 versus 336 min; P<0.001), clamping time (mean 81 versus 53 min; P<0.001), blood loss (mean 519 versus 286 ml; P=0.004), need for blood transfusion (six of 21 patients versus nine of 116; P=0.001), and rates of thoracophrenolaparotomy (eight of 21 versus 14 of 116; P<0.001) and resection of other tissues (six of 21 versus nine of 116; P<0.001) were significantly higher in the PAT group.
CONCLUSION: Hepatectomy after incomplete PAT is safe and effective, but more extensive procedures are necessary. The effect of salvage hepatectomy on long-term outcome is still unclear. Copyright (c) 2006 British Journal of Surgery Society Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17149716     DOI: 10.1002/bjs.5603

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Percutaneous ablation of post-surgical solitary early recurrence of colorectal liver metastases is an effective "test-of-time" approach.

Authors:  Luca Vigano; Jacopo Galvanin; Dario Poretti; Daniele Del Fabbro; Damiano Gentile; Vittorio Pedicini; Luigi Solbiati; Guido Torzilli
Journal:  Updates Surg       Date:  2021-04-12

2.  What we learned from difficult hepatectomies in patients with advanced hepatic malignancy.

Authors:  Bo Hyun Jung; Jae Hoon Lee; Sang Yeup Lee; Dae Keun Song; Ji Woong Hwang; Dae Wook Hwang; Young-Joo Lee; Kwang-Min Park
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-12-15

3.  Recurrent hepatocellular carcinoma successfully treated with laparoscopic thermal ablation.

Authors:  Roberto Santambrogio; Mara Costa; Matteo Barabino; Massimo Zuin; Emanuela Bertolini; Francesca De Filippi; Savino Bruno; Enrico Opocher
Journal:  Surg Endosc       Date:  2011-11-02       Impact factor: 4.584

Review 4.  Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma.

Authors:  Yoji Kishi; Kazuaki Shimada; Satoshi Nara; Minoru Esaki; Tomoo Kosuge
Journal:  World J Hepatol       Date:  2014-12-27

5.  Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Choice and Outcome.

Authors:  Xiaoyan Xie; Chunlin Jiang; Zhengwei Peng; Baoxian Liu; Wenjie Hu; Ye Wang; Manxia Lin; Mingde Lu; Ming Kuang
Journal:  J Gastrointest Surg       Date:  2015-05-27       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.